BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23658609)

  • 1. Changes in cancer cell metabolism revealed by direct sample analysis with MALDI mass spectrometry.
    Pirman DA; Efuet E; Ding XP; Pan Y; Tan L; Fischer SM; DuBois RN; Yang P
    PLoS One; 2013; 8(4):e61379. PubMed ID: 23658609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation.
    Yang P; Cartwright C; Chan D; Ding J; Felix E; Pan Y; Pang J; Rhea P; Block K; Fischer SM; Newman RA
    Mol Carcinog; 2014 Jul; 53(7):566-77. PubMed ID: 23371504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E3 metabolism and cancer.
    Yang P; Jiang Y; Fischer SM
    Cancer Lett; 2014 Jun; 348(1-2):1-11. PubMed ID: 24657656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucoselect Phytosome Modulates Serum Eicosapentaenoic Acid, Docosahexaenoic Acid, and Prostaglandin E3 in a Phase I Lung Cancer Chemoprevention Study.
    Mao JT; Xue B; Fan S; Neis P; Qualls C; Massie L; Fiehn O
    Cancer Prev Res (Phila); 2021 Jun; 14(6):619-626. PubMed ID: 33707173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells.
    Yang P; Chan D; Felix E; Cartwright C; Menter DG; Madden T; Klein RD; Fischer SM; Newman RA
    J Lipid Res; 2004 Jun; 45(6):1030-9. PubMed ID: 14993240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliable Entity Subtyping in Non-small Cell Lung Cancer by Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry on Formalin-fixed Paraffin-embedded Tissue Specimens.
    Kriegsmann M; Casadonte R; Kriegsmann J; Dienemann H; Schirmacher P; Hendrik Kobarg J; Schwamborn K; Stenzinger A; Warth A; Weichert W
    Mol Cell Proteomics; 2016 Oct; 15(10):3081-3089. PubMed ID: 27473201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myc Expression Drives Aberrant Lipid Metabolism in Lung Cancer.
    Hall Z; Ament Z; Wilson CH; Burkhart DL; Ashmore T; Koulman A; Littlewood T; Evan GI; Griffin JL
    Cancer Res; 2016 Aug; 76(16):4608-18. PubMed ID: 27335109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis.
    Chen WL; Kuo KT; Chou TY; Chen CL; Wang CH; Wei YH; Wang LS
    BMC Cancer; 2012 Jun; 12():273. PubMed ID: 22748147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enriching Islet Phospholipids With Eicosapentaenoic Acid Reduces Prostaglandin E
    Neuman JC; Schaid MD; Brill AL; Fenske RJ; Kibbe CR; Fontaine DA; Sdao SM; Brar HK; Connors KM; Wienkes HN; Eliceiri KW; Merrins MJ; Davis DB; Kimple ME
    Diabetes; 2017 Jun; 66(6):1572-1585. PubMed ID: 28193789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression.
    Jin H; Jang Y; Cheng N; Li Q; Cui PF; Zhou ZW; Jiang HL; Cho MH; Westover KD; Tan QY; Xu CX
    J Exp Clin Cancer Res; 2019 Apr; 38(1):165. PubMed ID: 30987652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin transporter (OATP2A1/SLCO2A1) contributes to local disposition of eicosapentaenoic acid-derived PGE3.
    Gose T; Nakanishi T; Kamo S; Shimada H; Otake K; Tamai I
    Prostaglandins Other Lipid Mediat; 2016 Jan; 122():10-7. PubMed ID: 26692285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and identification of potential biomarkers of non-small cell lung cancer.
    Yang Y; Zhao S; Fan Y; Zhao F; Liu Q; Hu W; Liu D; Fan K; Wang J; Wang J
    Technol Cancer Res Treat; 2009 Dec; 8(6):455-66. PubMed ID: 19925029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtyping non-small cell lung cancer by histology-guided spatial metabolomics.
    Neumann JM; Freitag H; Hartmann JS; Niehaus K; Galanis M; Griesshammer M; Kellner U; Bednarz H
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):351-360. PubMed ID: 34839410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors.
    Sharma SD; Meeran SM; Katiyar SK
    Mol Cancer Ther; 2010 Mar; 9(3):569-80. PubMed ID: 20145019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer.
    Heasley LE; Thaler S; Nicks M; Price B; Skorecki K; Nemenoff RA
    J Biol Chem; 1997 Jun; 272(23):14501-4. PubMed ID: 9169405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid MALDI profile classifies non-small cell lung cancers according to the histologic type.
    Lee GK; Lee HS; Park YS; Lee JH; Lee SC; Lee JH; Lee SJ; Shanta SR; Park HM; Kim HR; Kim IH; Kim YH; Zo JI; Kim KP; Kim HK
    Lung Cancer; 2012 May; 76(2):197-203. PubMed ID: 22099218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. n-3 Fatty acids regulate the inflammatory-state related genes in the lung epithelial cells exposed to polycyclic aromatic hydrocarbons.
    Gdula-Argasińska J; Czepiel J; Totoń-Żurańska J; Wołkow P; Librowski T; Czapkiewicz A; Perucki W; Woźniakiewicz M; Woźniakiewicz A
    Pharmacol Rep; 2016 Apr; 68(2):319-28. PubMed ID: 26922534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach.
    Caiola E; Falcetta F; Giordano S; Marabese M; Garassino MC; Broggini M; Pastorelli R; Brunelli L
    J Exp Clin Cancer Res; 2018 Dec; 37(1):302. PubMed ID: 30514331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eicosapentaenoic and docosahexaenoic acids have different effects on peripheral phospholipase A2 gene expressions in acute depressed patients.
    Su KP; Yang HT; Chang JP; Shih YH; Guu TW; Kumaran SS; Gałecki P; Walczewska A; Pariante CM
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):227-233. PubMed ID: 28648567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo.
    Brunelli L; Caiola E; Marabese M; Broggini M; Pastorelli R
    Sci Rep; 2016 Jun; 6():28398. PubMed ID: 27329432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.